Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial.

Salmerón, J; Ruiz-Extremera, A; Torres, C; Rodríguez-Ramos, L; Lavín, I; Quintero, D; Palacios, A

Salmerón, J; Ruiz-Extremera, A; Torres, C; Rodríguez-Ramos, L; Lavín, I; Quintero, D; Palacios, A.

Affiliation

Salmerón J; Hepatology Unit, Servicio de Digestivo, Hospital Clínico Universitario, Granada, Spain.

Liver ; 19(4): 275-80, 1999 Aug.

Article in En | MEDLINE | ID: mdl-10459624

Subject(s)

Antiviral Agents/therapeutic use; Hepatitis C, Chronic/therapy; Interferon-alpha/therapeutic use; Ribavirin/therapeutic use; Adult; Alanine Transaminase/blood; Biopsy; DNA Primers/chemistry; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus/drug effects; Hepacivirus/genetics; Hepatitis C, Chronic/enzymology; Hepatitis C, Chronic/virology; Humans; Interferon alpha-2; Male; Middle Aged; RNA, Viral/analysis; RNA, Viral/drug effects; Recombinant Proteins; Retrospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Ribavirin / Interferon-alpha / Hepatitis C, Chronic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Liver Year: 1999 Document type: Article Affiliation country: Spain Country of publication: Denmark

Search on Google

Add to My VHL

XML

PubMed Links